Actigraphic measurement of agitated behaviour in dementia
- 21 March 2006
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 21 (4) , 388-393
Abstract
Objectives This study examines the correlation between actigraphic measures and a validated assessment scale of agitated behaviour in dementia, the Cohen-Mansfield Agitation Inventory (CMAI). Methods A total of 110 patients were included. Patients either suffered from Alzheimer dementia (AD), mixed dementia (MXD), frontotemporal dementia (FTD) or diffuse Lewy body disease (DLB). All patients underwent actigraphic recordings for 48 h. CMAI was scored by professional caretakers, who were responsible for the patient during his or her actigraphic recording. Results Patients with high total CMAI scores (≥ 50) clearly had higher levels of activity during the day as measured by means of actigraphy than patients with low total CMAI scores (ANOVA, F = 126.75, p < 0.0001). Patients with low MMSE scores (< 20) also had higher activity levels during the day than patients with higher MMSE scores (ANOVA, F = 85.74, p < 0.0001). Correlations between actigraphic data and CMAI total scores were moderate but highly significant. Conclusion We conclude that actigraphy is a useful tool to examine agitated behaviour in dementia. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian studyInternational Journal of Geriatric Psychiatry, 2005
- Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidoneClinical Neurology and Neurosurgery, 2005
- Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer diseaseNeurobiology of Aging, 2004
- The effects of bright‐light therapy on actigraphical measured sleep last for several weeks post‐treatment. A study in a nursing home populationJournal of Sleep Research, 2004
- Quetiapine Treatment for Behavioral and Psychological Symptoms in Patients with Senile Dementia of Alzheimer TypeNeuropsychobiology, 2004
- Effect of Light Treatment on Sleep and Circadian Rhythms in Demented Nursing Home PatientsJournal of the American Geriatrics Society, 2002
- Gabapentin in the Treatment of Cocaine DependenceThe Journal of Clinical Psychiatry, 2001
- A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementiaNeurology, 1999
- A Description of Agitation in a Nursing HomeJournal of Gerontology, 1989
- “Mini-mental state”Journal of Psychiatric Research, 1975